HealthQuill WHO
The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency of international concern.
Drugs Health Pharma

WHO to convene emergency meeting on mpox on November 22

The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency.

Read More
One stillbirth occurs every 10 seconds and one-third of these occur between 20 and 28 weeks gestation, according to data from the Institute for Health Metrics and Evaluation.
Health Medical Pharma

One stillbirth occurs worldwide every ten seconds: US public health body says

One stillbirth occurs every 10 seconds and one-third of these occur between 20 and 28 weeks gestation, according to data from the Institute for.

Read More
The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from ensuring efficient preventive environments, according to a report from the independent Globsec.
Drugs Health Pharma

EU faces new healthcare threats, some states ‘miles away’ from ready 

The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from.

Read More
Egypt gets WHO certification for being a malaria-free country
Drugs Health Pharma

Egypt gets WHO certification for being a malaria-free country

Malaria, which plagued the ancient pharaohs, has been eliminated in Egypt, according to a World Health Organization-certificate, — the third such in in.

Read More
Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a secondary goal of a ‘high’ viral suppression rate in adults.
Drugs Health Pharma

Gilead, Merck’s HIV experimental drug scores ‘high’ on viral suppression

Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a.

Read More
Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future climate-related health threats, according to a  statement from the University of Glasgow.
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

Read More
India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise in coronary artery diseases, according to UK-based data analytics and consulting company, GlobalData.
Drugs Medical Pharma

Coronary drug-eluting stent market to grow 4% in India till 2033: Report

India’s coronary drug-eluting stent market may grow at a compound annual growth rate of 4% until 2033 on the back of a rise.

Read More
Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally, according to a World Health Organization report.
Drugs Health Pharma

Vaccines against pathogens can cut global antibiotic usage by 22%

Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,.

Read More
Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years, according to the Pan American Health Organization.
Health Medical Pharma

Dengue cases at an all-time high in Americas Region: PAHO report

Dengue cases in the Americas Region exceeded the number of cases historically reported in a year, as compared to all previously recorded years,.

Read More
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season compared to 94.1% in the first and 64.2% in the second.
Drugs Health Pharma

GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year

GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.

Read More